Rubius Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
C/O Verdolino & Lowey, P.C., 124 Washington Street, Suite 101, Foxboro, MA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/30/2024, 05:08 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Apr 10, 2023
SC 13G/A Report Mar 3, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report Feb 9, 2023
SC 13G/A Report Jan 20, 2023
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 11, 2022
SC 13G/A Report Feb 9, 2022
SC 13G/A Report Jan 26, 2022
SC 13G Report SC 13G Mar 8, 2021
SC 13G/A Report SC 13G/A Feb 16, 2021
SC 13G/A Report SEC SCHEDULE 13G Feb 16, 2021
SC 13G/A Report Feb 8, 2021
SC 13G/A Report Jan 27, 2021
SC 13G/A Report SC 13G/A Feb 14, 2020
SC 13G/A Report Feb 7, 2020
SC 13G/A Report Jan 17, 2020
SC 13G/A Report Nov 12, 2019
SC 13G Report SC 13G Feb 14, 2019
SC 13G Report Feb 13, 2019
SC 13G Report SC 13G Feb 13, 2019
SC 13G Report Jan 15, 2019